import { BlogPost } from '../types';

export const BLOG_POSTS_DATA: BlogPost[] = [
    // --- TIER 1: THE COMPARISON STRATEGY ---
    {
        id: 'reta-vs-tirze',
        title: "Retatrutide vs. Tirzepatide: Why the Triple Agonist is the 2026 Game Changer",
        excerpt: "Why the 'Triple Agonist' outperforms dual agonists in surgical precision and metabolic results.",
        content: `
      <p class="mb-6">Struggling with a Tirzepatide plateau? Want to understand the 2026 "Triple G" hype? In this post, we break down the clinical data and reconstitution protocols for Retatrutide.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Mechanism Breakdown (Triple vs. Dual)</h2>
      <p class="mb-4">While Tirzepatide targets GLP-1 and GIP, Retatrutide adds the Glucagon receptor (GCGR). This "Triple-G" agonism increases energy expenditure and suppresses appetite.</p>
      <div class="my-8 bg-white/5 p-6 rounded-2xl border border-white/10">
        <h3 class="text-lg font-bold text-evo-orange mb-4 uppercase">Key Comparison</h3>
        <p class="text-sm text-gray-400">Retatrutide showed an average weight loss of 24.2% at 48 weeks, compared to Tirzepatide's 20.9% at 72 weeks.</p>
      </div>
      <h2 class="text-2xl font-bold text-white mb-4">The Verdict</h2>
      <p class="mb-4">For breaking plateaus, Retatrutide's metabolic rate enhancement makes it the superior vanguard choice.</p>
    `,
        date: "Feb 21, 2026",
        category: "Comparison",
        readTime: "7 min",
        imageUrl: "/images/evo-dna.webp",
        purityBatch: "EVO-RT-0092",
        relatedProductId: "evo-retat-kit",
        references: [
            { label: "NEJM - Retatrutide Phase 2 Results", url: "https://www.nejm.org/doi/full/10.1056/NEJMoa2301972" },
            { label: "ClinicalTrials.gov - SYNERGY-Outcomes", url: "https://clinicaltrials.gov/ct2/show/NCT05869032" }
        ],
        faqs: [
            { question: "Is Retatrutide more stable than Tirzepatide?", answer: "Both are highly stable in lyophilized form when stored properly." },
            { question: "Does it require different BAC water?", answer: "No, Evo™ Standard BAC Water is optimized for all G-Series peptides." }
        ]
    },
    {
        id: 'reta-vs-mounjaro',
        title: "Is Retatrutide Better Than Mounjaro? A Head-to-Head Comparison",
        excerpt: "Comparing the clinical efficacy of Retatrutide against the current gold standard, Mounjaro.",
        content: `
      <p class="mb-6">Mounjaro has set the bar high, but Retatrutide is emerging as a more potent contender in metabolic research.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Receptor Affinity Comparison</h2>
      <p class="mb-4">Mounjaro (Tirzepatide) is a dual agonist. Retatrutide's inclusion of Glucagon receptor agonism provides a distinct thermogenic advantage.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Clinical Outcomes</h2>
      <p class="mb-4">Recent trials suggest Retatrutide achieves results faster and more consistently than Mounjaro in subjects with high metabolic resistance.</p>
    `,
        date: "Feb 20, 2026",
        category: "Comparison",
        readTime: "6 min",
        imageUrl: "/images/evo-retatrutide.webp",
        relatedProductId: "evo-retat-kit",
        references: [
            { label: "ClinicalTrials.gov - SYNERGY-Outcomes", url: "https://clinicaltrials.gov/ct2/show/NCT05869032" }
        ],
        faqs: [
            { question: "Can I switch from Mounjaro to Retatrutide?", answer: "Many researchers report successful transitions using a bridge protocol." }
        ]
    },
    {
        id: 'sema-to-reta',
        title: "The Evolution: From Semaglutide to Retatrutide",
        excerpt: "Tracking the journey from first-gen GLP-1 agonists to the 'Triple G' revolution.",
        content: `
      <p class="mb-6">The landscape of peptide research has shifted from simple satiety (Semaglutide) to dual-action hunger control, and now to triple-action metabolic overhaul.</p>
      <h2 class="text-2xl font-bold text-white mb-4">The Innovation Gap</h2>
      <p class="mb-4">Semaglutide was the foundation. Retatrutide is the apex, offering nearly 3x theoretical efficiency in some research models.</p>
    `,
        date: "Feb 19, 2026",
        category: "Comparison",
        readTime: "8 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "NIH - Retatrutide: A Game Changer in Obesity", url: "https://pubmed.ncbi.nlm.nih.gov/37363665/" }
        ]
    },
    {
        id: 'triple-vs-dual',
        title: "Why Triple Agonists Outperform Dual Agonists",
        excerpt: "A technical dive into GLP-1/GIP/GCG synergy.",
        content: `
      <p class="mb-6">Triple agonism represents a pharmacological synergy that dual agonists simply cannot match.</p>
      <h2 class="text-2xl font-bold text-white mb-4">The Glucagon Advantage</h2>
      <p class="mb-4">By activating the Glucagon receptor, Retatrutide increases liver glucose output regulation and lipolysis simultaneously.</p>
    `,
        date: "Feb 18, 2026",
        category: "Comparison",
        readTime: "9 min",
        imageUrl: "/images/evo-retatrutide.webp",
        references: [
            { label: "ACS Journal - Strategic Design of Triple Agonists", url: "https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02115" }
        ]
    },
    {
        id: 'reta-vs-cagrisema',
        title: "Retatrutide vs. CagriSema: Which is Winning the Race?",
        excerpt: "Comparing the two most anticipated future peptides.",
        content: `
      <p class="mb-6">CagriSema and Retatrutide are both in late-stage trials. While CagriSema relies on amylin agonism, Retatrutide focuses on glucagon.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Data Analysis</h2>
      <p class="mb-4">Retatrutide currently holds the record for the highest percentage weight loss in a Phase 2 trial.</p>
    `,
        date: "Feb 17, 2026",
        category: "Comparison",
        readTime: "7 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "The Lancet - CagriSema vs Tirzepatide Insights", url: "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01160-2/fulltext" }
        ]
    },
    // --- TIER 2: THE HOW-TO & TECHNICAL ---
    {
        id: 'reconstitution-guide',
        title: "Retatrutide Reconstitution Guide: 20mg Kit Protocol",
        excerpt: "Step-by-step laboratory guide for reconstituting your Evo™ Retatrutide.",
        content: `
      <p class="mb-6">Proper reconstitution is vital for maintaining peptide structural integrity.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Laboratory Supplies</h2>
      <ul class="list-disc pl-6 mb-6 text-gray-400">
        <li>Evo™ Retatrutide 20mg Lyophilized Powder</li>
        <li>Evo™ Bacteriostatic Water (3mL)</li>
        <li>Alcohol Prep Pads</li>
        <li>Standard 1mL Insulin Syringe</li>
      </ul>
      <h2 class="text-2xl font-bold text-white mb-4">The Reconstitution Steps</h2>
      <p class="mb-4">Gently introduce the BAC water via the side-wall of the vial. Do NOT spray directly onto the powder.</p>
    `,
        date: "Feb 16, 2026",
        category: "Technical",
        readTime: "5 min",
        imageUrl: "/images/evo-landing-header.webp",
        relatedProductId: "evo-retat-kit",
        references: [
            { label: "Drugs.com - Retatrutide Research Dosage", url: "https://www.drugs.com/dosage/retatrutide.html" }
        ],
        faqs: [
            { question: "Should I shake the vial?", answer: "No, always gently swirl. Shaking can denature the peptide sequence." }
        ]
    },
    {
        id: 'hplc-purity-importance',
        title: "The Importance of HPLC Purity: Why >99.9% Matters",
        excerpt: "Understanding laboratory verification in peptide research.",
        content: `
      <p class="mb-6">In research, purity is not a suggestion; it is a requirement for valid results.</p>
      <h2 class="text-2xl font-bold text-white mb-4">What is HPLC?</h2>
      <p class="mb-4">High-Performance Liquid Chromatography (HPLC) is the industry standard for chemical verification.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Evo™ Quality Control</h2>
      <p class="mb-4">Batch #EVO-RT-0092 shows a purity profile exceeding 99.9%, ensuring no off-target effects.</p>
    `,
        date: "Feb 15, 2026",
        category: "Technical",
        readTime: "6 min",
        imageUrl: "/images/evo-dna.webp",
        purityBatch: "EVO-RT-0092",
        references: [
            { label: "Patsnap Synapse - Retatrutide Standards", url: "https://synapse.patsnap.com/drug/retatrutide" }
        ]
    },
    {
        id: 'glucagon-receptor-science',
        title: "Understanding the Glucagon (GCG) Receptor",
        excerpt: "The secret to increased energy expenditure in the Triple-G model.",
        content: `
      <p class="mb-6">The GCGR is what separates Retatrutide from everything that came before.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Thermogenesis and Energy</h2>
      <p class="mb-4">Activation of GCGR signals the liver to utilize fat stores for energy, effectively increasing the metabolic 'idle' speed.</p>
    `,
        date: "Feb 14, 2026",
        category: "Technical",
        readTime: "9 min",
        imageUrl: "/images/evo-retatrutide.webp",
        references: [
            { label: "Nature Metabolism - Glucagon Signaling", url: "https://www.nature.com/articles/s42255-020-0220-4" }
        ]
    },
    {
        id: 'storage-101',
        title: "Retatrutide Storage 101: Maintaining Potency",
        excerpt: "How cold-chain logistics and proper home storage protect your research.",
        content: `
      <p class="mb-6">Peptides are fragile bio-molecules. Heat and light are the enemies of potency.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Recommended Protocol</h2>
      <p class="mb-4">Store lyophilized vials in a dark refrigerator at 2-8°C. Once reconstituted, usage window is 30 days.</p>
    `,
        date: "Feb 13, 2026",
        category: "Technical",
        readTime: "5 min",
        imageUrl: "/images/evo-landing-header.webp",
        references: [
            { label: "Lilly Investor News - Handling Incretins", url: "https://investor.lilly.com/news-releases" }
        ]
    },
    {
        id: 'peptide-math',
        title: "Peptide Math: Calculating Doses for 20mg Vials",
        excerpt: "A simple guide to micro-dosing and syringe mathematics.",
        content: `
      <p class="mb-6">Never guess your research volume. Use the following formula for precision.</p>
      <h2 class="text-2xl font-bold text-white mb-4">The Calculation Formula</h2>
      <p class="mb-4">Total mg ÷ Total mL = mg per mL. For a 20mg vial with 2mL BAC, you have 10mg/mL.</p>
    `,
        date: "Feb 12, 2026",
        category: "Technical",
        readTime: "4 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "Journal of Clinical Investigation - Dosing Models", url: "https://www.jci.org/" }
        ],
        faqs: [
            { question: "How many units is 2mg?", answer: "In a 20mg/2mL concentration, 2mg is 20 units (0.2mL)." }
        ]
    },
    // --- TIER 3: RESULTS & EXPECTATIONS ---
    {
        id: 'clinical-trial-results',
        title: "Clinical Trial Results: What Phase 3 Data Tells Us",
        excerpt: "Analyzing the record-breaking TRIUMPH-4 data.",
        content: `
      <p class="mb-6">The Phase 3 TRIUMPH-4 data has officially shifted the ceiling for metabolic outcomes.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Topline Findings</h2>
      <p class="mb-4">Subjects achieved up to 28.7% weight reduction over 48 weeks, making it the most potent agonist in clinical history.</p>
    `,
        date: "Feb 11, 2026",
        category: "Results",
        readTime: "7 min",
        imageUrl: "/images/evo-retatrutide.webp",
        references: [
            { label: "Eli Lilly News - Phase 3 Results", url: "https://investor.lilly.com/news-releases" }
        ]
    },
    {
        id: 'realistic-timeline',
        title: "The 'Triple G' Effect: Realistic Research Timeline",
        excerpt: "What to expect from month 1 to month 12.",
        content: `
      <p class="mb-6">Setting realistic benchmarks is critical for evaluating protocol success.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Month 1: Induction</h2>
      <p class="mb-4">Expect immediate appetite suppression and a shift in metabolic rate within 72 hours of the first dose.</p>
    `,
        date: "Feb 10, 2026",
        category: "Results",
        readTime: "6 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "NEJM - 48-week Weight Loss Data", url: "https://www.nejm.org/doi/full/10.1056/NEJMoa2301972" }
        ]
    },
    {
        id: 'fat-vs-muscle',
        title: "Retatrutide: Fat Loss vs. Muscle Preservation",
        excerpt: "Does the Triple Agonist protect lean mass?",
        content: `
      <p class="mb-6">Rapid weight loss often comes at the cost of muscle. How does Retatrutide stack up?</p>
      <h2 class="text-2xl font-bold text-white mb-4">Preserving Structure</h2>
      <p class="mb-4">Data suggests that due to its metabolic efficiency, Retatrutide can help researchers preserve a better lean-to-fat mass ratio than simple starvation diets.</p>
    `,
        date: "Feb 09, 2026",
        category: "Results",
        readTime: "8 min",
        imageUrl: "/images/evo-retatrutide.webp",
        references: [
            { label: "Clinical Trials Arena - Analysis", url: "https://www.clinicaltrialsarena.com/news/lilly-retatrutide-phase-2-obesity/" }
        ]
    },
    {
        id: 'breaking-plateaus',
        title: "Overcoming Stalls: Breaking a Plateau with Retatrutide",
        excerpt: "Strategies for switching protocols when progress slows.",
        content: `
      <p class="mb-6">Many researchers hit a wall with Tirzepatide or Semaglutide. Here is how to break it.</p>
      <h2 class="text-2xl font-bold text-white mb-4">The Switch Protocol</h2>
      <p class="mb-4">Moving to a Triple Agonist can re-sensitize receptors and restart metabolic progress almost immediately.</p>
    `,
        date: "Feb 08, 2026",
        category: "Results",
        readTime: "5 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "Diabetes Journal - Incretin Switching", url: "https://dom-pubs.onlinelibrary.wiley.com/" }
        ]
    },
    {
        id: 'first-4-weeks',
        title: "What to Expect in the First 4 Weeks",
        excerpt: "Preparation guide for the initial phase of research.",
        content: `
      <p class="mb-6">The first month is about loading and adaptation.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Phase 1 Milestones</h2>
      <p class="mb-4">Expect a marked decrease in 'food noise' and a steady decrease in non-essential adipose tissue.</p>
    `,
        date: "Feb 07, 2026",
        category: "Results",
        readTime: "4 min",
        imageUrl: "/images/evo-landing-header.webp",
        references: [
            { label: "PR Newswire - Patient Outcomes", url: "https://www.prnewswire.com/" }
        ]
    },
    // --- TIER 4: SAFETY & LIFESTYLE ---
    {
        id: 'managing-side-effects',
        title: "Managing Side Effects: A Comfortable Research Guide",
        excerpt: "How to mitigate nausea and other common adaptions.",
        content: `
      <p class="mb-6">Most side effects are manageable with the right ancillary protocols.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Mitigation Strategies</h2>
      <p class="mb-4">Hydration and slow titration are the two most effective ways to avoid protocol downtime.</p>
    `,
        date: "Feb 06, 2026",
        category: "Safety",
        readTime: "9 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "ResearchGate - Safety Meta-Analysis", url: "https://www.researchgate.net/" }
        ]
    },
    {
        id: 'mandatory-hplc-testing',
        title: "Why Purity Testing is Mandatory for Quality Research",
        excerpt: "The risks of unverified chemicals in the laboratory.",
        content: `
      <p class="mb-6">Inaccurate sequences lead to inaccurate data. Never skip verification.</p>
      <h2 class="text-2xl font-bold text-white mb-4">The Danger of Impurities</h2>
      <p class="mb-4">Lower purity chemicals can contain TFA (Trifluoroacetic acid) which is toxic in laboratory settings.</p>
    `,
        date: "Feb 05, 2026",
        category: "Safety",
        readTime: "6 min",
        imageUrl: "/images/evo-retatrutide.webp",
        purityBatch: "EVO-RT-0092",
        references: [
            { label: "FDA - Purity Standards for Peptides", url: "https://www.fda.gov/" }
        ]
    },
    {
        id: 'science-of-satiety',
        title: "The Science of Satiety: How the brain rewires appetite",
        excerpt: "Neurological mechanisms of GLP-1 and GIP signaling.",
        content: `
      <p class="mb-6">Retatrutide works on the CNS to permanently alter appetite behavior during research.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Central Nervous System Activation</h2>
      <p class="mb-4">By targeting the hypothalamus, these agonists effectively disable the hunger signal at its source.</p>
    `,
        date: "Feb 04, 2026",
        category: "Safety",
        readTime: "8 min",
        imageUrl: "/images/evo-dna.webp",
        references: [
            { label: "ScienceDirect - CNS Activation", url: "https://www.sciencedirect.com/" }
        ]
    },
    {
        id: 'liver-health-nash',
        title: "Retatrutide and Liver Health: Exploring NASH/MASH",
        excerpt: "The surprising benefits for hepatic triglyceride reduction.",
        content: `
      <p class="mb-6">Beyond weight loss, Retatrutide shows immense promise for liver-related metabolic research.</p>
      <h2 class="text-2xl font-bold text-white mb-4">Hepatic Fat Reduction</h2>
      <p class="mb-4">In recent trials, retatrutide showed a significant reduction in liver fat, which is critical for NASH research.</p>
    `,
        date: "Feb 03, 2026",
        category: "Safety",
        readTime: "7 min",
        imageUrl: "/images/evo-retatrutide.webp",
        references: [
            { label: "AJP - Liver Physiology Research", url: "https://journals.physiology.org/journal/ajpgi" }
        ]
    },
    {
        id: 'buying-peptides-online',
        title: "Buying Peptides Online: 5 Red Flags to Watch For",
        excerpt: "How to verify a domestic vendor and avoid common scams.",
        content: `
      <p class="mb-6">The online marketplace is full of uncertainty. Here is how Evo stands apart.</p>
      <h2 class="text-2xl font-bold text-white mb-4">What to Look For</h2>
      <p class="mb-4">Always demand HPLC reports and look for domestic ready-stock to avoid customs risk.</p>
    `,
        date: "Feb 02, 2026",
        category: "Safety",
        readTime: "5 min",
        imageUrl: "/images/evo-landing-header.webp",
        references: [
            { label: "NIH - Online Marketplace Risks", url: "https://www.nih.gov/" }
        ]
    }
];
